AI summary Trust: medium Third-party lab

Janoshik tested this tirzepatide at 99.87% purity via HPLC. The tested quantity of 34.15mg showed a significant deviation of +13.83% from the 30mg label. Endotoxin status is unknown, and the test is recent (3-6 months old). Customers can cross-check on the lab's public verification URL.

Watch out for
  • no endotoxin test
  • quantity deviation (+13.83%)
Test date
2025-12-02
Purity
99.87% 99.898%; 99.868%; 99.870%.
Batch / lot
—
Lab
Janoshik
Quantity
label 30mg tested 34.15mg
Qty vs label
+13.8%
Endotoxins
—
Test score
—
Manufacturer
Uther Peptide
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Janoshik (public)

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC
Dose
30mg
Catalogued
2026-04-24
Artifact hash
fc51517d46ce8e1a…
OCR text

Raw extracted text

Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display. 

{"peptide": "Tirzepatide", "dose": "30mg", "purity_pct": 99.87, "purity_label": "99.898%; 99.868%; 99.870%.", "method": "HPLC", "test_date": "2025-12-02", "client": "utherpeptide.com", "notes": "", "label_qty": "30mg", "tested_qty": "34.15mg", "quantity_deviation_pct": 13.83, "is_blend": false, "components_json": "", "ocr_confidence": 0.95}
This COA is part of TitrateLab's community-trust corpus. See more from Uther Peptide or learn how trust scores are computed on the methodology page.